Stocksigma LogoStocksigma Logo

Procter & Gamble Health Reports Strong Q2 Results with 26% PAT Growth

Procter & Gamble Health Ltd. reported robust Q2 financial results for the period ended 30th Sep'26. Sales rose 18% YoY to ₹376 crore, supported by strong

Procter & Gamble Health Reports Strong Q2 Results with 26% PAT Growth

Procter & Gamble Health Ltd · Press Release · 02 Nov 2026, 8:23 pm

Procter & Gamble Health Reports Strong Q2 Results with 26% PAT Growth Procter & Gamble Health Ltd. reported robust Q2 financial results for the period ended 30th Sep'26. Sales rose 18% YoY to ₹376 crore, supported by strong brand fundamentals, improved retail execution, favorable consumer response to new innovations, and enhanced go-to-market execution. Reported Profit After Tax (PAT) climbed 26% YoY to ₹112 crore, driven by top-line expansion and sustained productivity gains across the value chain. Growth across key healthcare and VMS brands reflected rising consumer demand for preventive healthcare.

Original exchange filing (PDF)

More announcements from Procter & Gamble Health Ltd

All Procter & Gamble Health Ltd announcements